PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
Hodgkin lymphoma (HL) is among the neoplastic diseases that has the best long-term outcome after cytotoxic treatment. Cure rates approach 80-90%, however, 15-20% of patients will be resistant to therapy (primary refractory) or relapse after treatment. Prognostic factors should help to stratify ther...
Saved in:
Main Authors: | Annarosa Cuccaro, Francesca Bartolomei, Elisa Cupelli, Stefan Hohaus |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2014-07-01
|
Series: | Mediterranean Journal of Hematology and Infectious Diseases |
Subjects: | |
Online Access: | http://www.mjhid.org/index.php/mjhid/article/view/1374 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of C-reactive protein and its prognostic relationship in patients with Hodgkin's Lymphoma
by: Elizete Negreiros, et al.
Published: (2024-12-01) -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
by: Claudio Agostinelli, et al.
Published: (2014-06-01) -
THE EVOLVING ROLE OF RADIOTHERAPY IN EARLY STAGE HODGKIN’S LYMPHOMA
by: Umberto Ricardi, et al.
Published: (2014-05-01) -
A rare immune-related mesenteric and retroperitoneal serositis in a multirefractory Hodgkin lymphoma patient successfully treated with chylolymphostatic surgery
by: Matteo D'Addona, et al.
Published: (2023-10-01) -
Interfollicular Hodgkin’s lymphoma: A diagnostic challenge for pathologists
by: Maneesh K. Vijay, et al.
Published: (2023-03-01)